Skip to content

Study on the improvement of visual function and optic disc vessel density in non-acute stage diabetic optic neuropathy by eye acupuncture

tudy on the improvement of visual function and optic disc vessel density in non-acute stage diabetic optic neuropathy by eye acupuncture

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000532
Enrollment
Unknown
Registered
2024-10-12
Start date
2024-02-05
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic optic neuropathy

Interventions

Control group:Pseudoacupuncture + basic treatment
Experimental group:Eye acupuncture + basic treatment

Sponsors

China Academy of Chinese Medical Sciences Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet DON non-acute stage staging criteria; (2) Age 40-75 years old; (3) TCM syndrome differentiation of Qi deficiency and blood stasis; (4) signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Poor refractive interstitial clarity difficult to perform fundus observer; (2) Patients with age-related macular degeneration glaucoma retinal vein obstruction uveitis and other optic nerve diseases; (3) Patients with severe cardiovascular cerebrovascular liver and hematopoietic system diseases; (4) Patients with serious life-threatening primary diseases and mental disorders; (5) Pregnant or lactating women; (6) Participants in other clinical trials; (7) The examination process can not cooperate can not adhere to the tracking of the fundus examination.

Design outcomes

Primary

MeasureTime frame
Mean sensitivity;Liver and kidney function;Best corrected visual acuity; Mean visual field defect;

Secondary

MeasureTime frame
Optical coherence tomography angiography;

Countries

China

Contacts

Public ContactJie Chuanhong

China Academy of Chinese Medical Sciences Eye Hospital

jiechuanhong@163.com18810959064

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026